Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease

Open access

Published version of a preprint

Abstract

Protein-truncating variants (PTVs) affecting dyslipidemia risk may point to therapeutic targets for cardiometabolic disease. Our objective was to identify PTVs that were associated with both lipid levels and the risk of coronary artery disease (CAD) or type 2 diabetes (T2D) and assess their possible associations with risks of other diseases. To achieve this aim, we leveraged the enrichment of PTVs in the Finnish population and tested the association of low-frequency PTVs in 1,209 genes with serum lipid levels in the Finrisk Study (n = 23,435). We then tested which of the lipid-associated PTVs were also associated with the risks of T2D or CAD, as well as 2,683 disease endpoints curated in the FinnGen Study (n = 218,792). Two PTVs were associated with both lipid levels and the risk of CAD or T2D: triglyceride-lowering variants in ANGPTL8 (-24.0[-30.4 to -16.9] mg/dL per rs760351239-T allele, P = 3.4 × 10 −9 ) and ANGPTL4 (-14.4[-18.6 to -9.8] mg/dL per rs746226153-G allele, P = 4.3 × 10 −9 ). The risk of T2D was lower in carriers of the ANGPTL4 PTV (OR = 0.70[0.60–0.81], P = 2.2 × 10 −6 ) than noncarriers. The odds of CAD were 47% lower in carriers of a PTV in ANGPTL8 (OR = 0.53[0.37–0.76], P = 4.5 × 10 −4 ) than noncarriers. Finally, the phenome-wide scan of the ANGPTL8 PTV showed that the ANGPTL8 PTV carriers were less likely to use statin therapy (68,782 cases, OR = 0.52[0.40–0.68], P = 1.7 × 10 −6 ) compared to noncarriers. Our findings provide genetic evidence of potential long-term efficacy and safety of therapeutic targeting of dyslipidemias.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1009501

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 An overview of the present study. a Abbreviations: PTV, protein-truncating variant; MAF, minor-allele frequency; HDL-C, high-density lipoprotein cholesterol level; ln(TG), natural logarithm of triglyceride level; LDL-C, low-density lipoprotein cholesterol level; TC, total cholesterol level; T2D, type 2 diabetes; CAD, coronary artery disease. a Shown in the figure is an overview of the present study. The final results are shown in boxes with a bolded font. b Results for these association tests were also compared with other PTVs in UK Biobank. c These association tests were post-hoc in nature.
Fig 1 An overview of the present study. a Abbreviations: PTV, protein-truncating variant; MAF, minor-allele frequency; HDL-C, high-density lipoprotein cholesterol level; ln(TG), natural logarithm of triglyceride level; LDL-C, low-density lipoprotein cholesterol level; TC, total cholesterol level; T2D, type 2 diabetes; CAD, coronary artery disease. a Shown in the figure is an overview of the present study. The final results are shown in boxes with a bolded font. b Results for these association tests were also compared with other PTVs in UK Biobank. c These association tests were post-hoc in nature.CC BY · PubMed Central
Fig 2 Mean serum triglyceride levels of ANGPTL4 and ANGPTL8 PTV heterozygotes at their self-reported fasting time in the Finrisk Study. a a The figure shows the mean serum triglyceride level by ANGPTL4 and ANGPTL8 PTV carrier status with respect to self-reported fasting time. The number of ANGPTL4 and ANGPTL8 heterozygotes for each fasting time interval are reported below the fasting time legend. The height of the bars indicate means and the error bars 95% confidence intervals. The P values are for the two-sided Welch’s t-test of the natural logarithm of triglyceride levels between noncarriers and heterozygotes.
Fig 2 Mean serum triglyceride levels of ANGPTL4 and ANGPTL8 PTV heterozygotes at their self-reported fasting time in the Finrisk Study. a a The figure shows the mean serum triglyceride level by ANGPTL4 and ANGPTL8 PTV carrier status with respect to self-reported fasting time. The number of ANGPTL4 and ANGPTL8 heterozygotes for each fasting time interval are reported below the fasting time legend. The height of the bars indicate means and the error bars 95% confidence intervals. The P values are for the two-sided Welch’s t-test of the natural logarithm of triglyceride levels between noncarriers and heterozygotes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 47

Metadata

Authors
Helkkula, P., Kiiskinen, T., Havulinna, A. S., Karjalainen, J., Koskinen, S., Salomaa, V., Daly, M. J., Palotie, A., Surakka, I., Ripatti, S., & FinnGen
Affiliations
  • University of Helsinki (FI)
  • Broad Institute (US)
  • Finnish Institute for Health and Welfare (FI)
Corresponding author
Ripatti, Samuli
Venue
PLOS Genetics
Published
2021-04-28
Volume
17
Issue
4
Pages
e1009501
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W3157950658
Cited by
47
References
58
Citations by year
2026: 5 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 8 · 2021: 8
FWCI
5.52
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
  • WOS
Funders
  • Business Finland (HUS 4685/31/2016 and UH 4386/31/2016)
  • Sigrid Juséliuksen Säätiö
  • University of Helsinki HiLIFE
  • Academy of Finland Center of Excellence in Complex Disease Genetics (312062, 336820, 312074, 336824, 312075, 336821)
  • Academy of Finland (285380, 128650, 321356)
  • Horizon 2020 (101016775, 66730)
  • Sydäntutkimussäätiö
  • Precision Health Scholars Award from the University of Michigan Medical School
  • Doctoral Programme in Population Health, University of Helsinki
  • Emil Aaltosen Säätiö
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
ANGPTL8, ANGPTL4, truncating mutations, serum triglycerides, coronary artery disease, type 2 diabetes, dyslipidemia, low-frequency variants, statin therapy, phenome-wide association study, therapeutic target, cardiometabolic disease, Finnish population, FINRISK Study
MeSH terms
Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Aged, Coronary Artery Disease, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Risk Factors, Triglycerides, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Peptide Hormones, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease. https://app.cochat.ai/papers/10.1371/journal.pgen.1009501
The paper
Helkkula, P., Kiiskinen, T., Havulinna, A. S., Karjalainen, J., Koskinen, S., Salomaa, V., Daly, M. J., Palotie, A., Surakka, I., Ripatti, S., & FinnGen. (2021). ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1009501

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.